| Preferred Name |
gadodiamide |
| Synonyms |
Gd-DTPA-BMA |
| ID |
http://purl.bioontology.org/ontology/MESH/C064925 |
| altLabel |
Gd-DTPA-BMA Gadolinium, aqua(5,8-bis(carboxymethyl)-11-(2-(methylamino)-2-oxoethyl)-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-))-, hydrate Omniscan Omniscan Unique Softpack Gd-DTPA bis-(methylamide) |
| cui |
C0722252 C0082646 |
| HM |
D019786 |
| II |
D007275 |
| Inverse of RB |
84F6U3J2R6 |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
19900815 |
| MeSH Frequency |
1203 |
| MMR |
20161222 |
| notation |
C064925 |
| PA |
D003287 |
| PI |
*DTPA (90-93) *ORGANOMETALLIC COMPOUNDS (94-97) DTPA/*analogs & derivatives (94-97) |
| prefLabel |
gadodiamide |
| RR |
122795-43-1 |
| SC |
1 |
| Scope Statement |
for intravenous administration with MRI in adult patients for contrast enhancement of CNS lesions |
| SRC |
Radiology 1990;176(2):451 |
| TERMUI |
T208727 T208728 T208730 T635724 T208729 |
| TH |
FDA SRS (2015) USAN (1990) US DE NLM (1990) CA AU INN (19XX) ES |
| tui |
T109 T130 |